Sequencing Reagents Market Size, Share & Trends Analysis Report By Technology (Sanger Sequencing, NGS, 3G), By Type (Library Kits, Template Kits), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

Sequencing Reagents Market Size, Share & Trends Analysis Report By Technology (Sanger Sequencing, NGS, 3G), By Type (Library Kits, Template Kits), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030

Sequencing Reagents Market Growth & Trends

The global sequencing reagents market size is expected to reach USD 21.91 billion in 2030 and is projected to grow at a CAGR of 17.8% from 2025 to 2030 Emergence of advanced and rapid high-throughput technologies, such as next-generation sequencing (NGS) and third-generation sequencing (TGS), for use in clinical applications provides lucrative growth avenues.

Moreover, a confluence of factors such as advent of targeted therapies in oncology and other clinical fields, development of companion diagnostics and precision medicine, and a significant reduction in the cost of genetic sequencing has increased the installation of NGS platforms throughout the globe. This, in turn, positively influences revenue generation for the market.

A substantial number of companies are using high-throughput technologies for drug discovery, which demands the use of genetic sequencing technologies. In addition, the application of NGS to accelerate early identification of autoimmune disorders is expected to drive the market. Moreover, parallel innovations in biomedical sciences have contributed to the growth of the NGS market.

Players in the industry are focused on in-depth research and development of new and effective reagents to stay ahead in the market. For instance, in October 2018, F. Hoffmann-La Roche AG introduced three NGS AVENIO Tumor Tissue Analysis Kits for detection of mutation in tumors. Similarly, in October 2019, QIAGEN launched an RNA-seq library preparation kit called QIAseq FastSelect RNA Removal Kit, designed for NGS. Companies are also expanding their businesses and setting up new facilities across the globe to gain a stronger foothold. For instance, in January 2019, BGI’s subsidiary, MGI, installed 1,000 sequencers in 16 countries and opened an early access program for MGISEQ-T7 sequencer.

Sequencing Reagents Market Report Highlights

• Next-generation sequencing (NGS) dominated the market and accounted for a share of 91.7% in 2024. Next-generation sequencing (NGS) is extensively utilized in molecular diagnostics, pathology, and clinical research due to its cost efficiency and high throughput.
• Sequencing kits led the market with a revenue share of 35.7% in 2024 owing to the availability of major high-throughput platforms such as Illumina's MiniSeq, MiSeq, iSeq, NextSeq, HiSeq X, and NovaSeq series; Thermo Fisher Scientific's PGM, IonS5, and Ion Proton system; and Oxford Nanopore Technologies plc's MinION, GridION X5, and PromethION.
• Applications in oncology held the largest market share of 31.7% in 2024, driven by the extensive use of sequencing reagents in clinical research and advancements in cancer diagnostics and therapeutics
• Academic research led the market and accounted for a share of 50.0% in 2024, with numerous universities and research centers offering molecular biology courses that extensively employ next-generation sequencing (NGS) techniques.
• The clinical research segment is projected to grow at the fastest CAGR of 21.6 over the forecast period

Please note The report will be delivered in 2-3 business days upon order notification.